Review
Evaluation
Target price
Dynamics
Performance
Growth
Dividends
Risks
₹ 1559.5
Key Takeaways
Risk factor
Very poor trading liquidity
Data is available to registered users only
Data is available to registered users only
Profitability factor
Good growth
Data is available to registered users only
Data is available to registered users only
About
Fredun Pharmaceuticals Ltd. engages in the manufacture and sale of pharmaceuticals, neutraceuticals, herbal and dietary supplements. It also offers animal healthcare products. The company was founded by Nariman Bamansha Medhora on June 8, 1987 and is headquartered in Mumbai, India.
Company Valuation
Based on key historical and expected multiples, the stock is fairly valued relative to its peers. Specifically, the stock is fairly valued on P/E, neutral on EV/EBITD.
Data is available to registered users only
Buy
Sell